Page 4315 - Markets News

Traders cautious on delisting after Ricoh India bets turn sour

Distinctly less agression in AstraZeneca and Essar Oil cases after earlier bet on Ricoh went sour; fear of stock price fall

Crowd-funding not for the crowd

Sebi's draft norms requiring use of demat accounts could exclude 90 per cent of potential investors

Today's picks

Nifty, Bank Nifty, Maruti, IDFC & Coal India

Sensex dips 55 pts

BSE F&O turnover down 49% from record high

The movements have come ahead of the expiry of this month's derivative contracts tomorrow

S&P Dow Jones Indices set long-term growth plans in India

We are looking at growing in Indian market by introducing more products, says S&P Dow Jones Indices MD

Analysts will need professional degree, NISM certificate: Sebi

The new norms will ensure that investors get the right financial advice

Unions to oppose investment of EPFO funds in equity market

We opposed it earlier and will oppose it again as it is poor workers money, says All India General Secretary of Bharatiya Mazdoor Sangh

Markets end lower ahead of June F&O expiry

Markets ended lower on profit taking ahead of June F&O expiry

Indian Hotels hits 4-year high on fund raising plans

The company will issue 9 compulsorily convertible debenture for every 40 equity shares to raise up to Rs 1,000 crore via rights issue.

Sensex slips nearly 60 points on profit booking

Broader markets outperformed benchmark indices as BSE Mid-cap and Small-cap indices gained over 0.50

IRB Infra hits three-year high; stock zooms over 140% in 2014

So far in 2014, the stock has surged 144% to Rs 227 from Rs 93, compared to 20% rise S&P BSE Sensex.

Lupin, Biocon, Aurobindo, Torrent Pharma hit new high

Sun Pharma, Strides Arcolab, Wockhdart, Ranbaxy and Dr Reddy's Lab are trading higher by up to 4% on the BSE.

Nifty June series expiry seen around 7,500-7,520: Shshank Mehta

Check out the F&O trends in select stocks with Shshank Mehta, Independent Derivative Analyst

Markets trading flat; Bajaj Auto up 2%

Markets trimmed most of the losses and were trading flat helped by gains in SBI

Rupee stays weak at 60.28

Almost all Asian currencies slide against the dollar

Jhunjhunwala betting highly on retail

BCG expects sector to grow to $200 bn in 5-7 years

Indices trade weak; Oil shares slip

The broader markets outshined their Largecap counterparts. BSE Mid-cap and BSE Small-cap appreciated 0.5% each.

Strides Arcolab gains on USFDA nod for Imiquimod cream

The stock has moved higher by 6% to Rs 639 on the Bombay Stock Exchange.

Telcos under pressure; RCom down 3%

Bharti Airtel and Idea Cellular are down 2% each on the Bombay Stock Exchange.